NEWS
By Gail MarksJarvis | September 7, 2008
It's a star-studded cast in mutual funds - and also a shocking flop on this year's complex investing stage. With the financial crisis playing out in ways many professionals failed to predict, and oil also surprising, some of the best and brightest of the fund business have turned into the biggest losers of the year. They include exalted names such as Bill Miller of Baltimore-based Legg Mason Value fund, Martin Whitman of Third Avenue Value fund, David Dreman of DWS Dreman High Return, Wally Weitz of Weitz Value, Mason Hawkins and Staley Cates of the Longleaf Partners team, Christopher Davis and Kenneth Feinberg of Davis New York Venture, and the team that manages American Funds Amcap fund.
NEWS
By Jay Hancock | July 11, 2007
Which Maryland congressman owed more than $10,000 in credit-card debt last year? Which one lost tens of thousands of dollars investing in his brother-in-law's company? Which Maryland senator gave the old portfolio a political face-lift? The answers, in the forms that senators and representatives just filed showing the previous year's financial activity, are worth a peek. If the measure of a man is revealed first in his friendships and second in what he reads, where he puts his money can't be far behind.
NEWS
By ANDREW LECKEY | August 13, 2006
Why hasn't Eli Lilly & Co. stock performed better? It's a big retirement holding of mine. - R.C., via the Internet Although the pharmaceutical giant will continue to be a big-time player, its lowered expectations for the rest of this year have taken a toll on its stock. After previously forecasting 7 percent to 9 percent sales growth for 2006, management now expects results in the lower end of that range. That's due in part to disappointing sales of its insulin drugs. It also faces increased competition for its Zyprexa antipsychotic medication, which is its top-selling drug but has seen its sales slip slightly in the United States.
NEWS
By GAIL MARKSJARVIS | January 22, 2006
The stock market threw a party for investors during the first few days of this year. But if you think you were part of the festivities, you had better take a look at your portfolio. You might have left yourself off the guest list. The action recently has centered on growth stocks, relatively large company stocks and the mutual funds that invest in them - the funds that many investors dumped in terror as stocks crashed during the early 2000s. Another winner during the past two years has been international funds, an investment that countless investors fled in the late 1990s as the Asian financial crisis destroyed fortunes in developing markets.
NEWS
By BLOOMBERG NEWS | October 8, 2005
Wallace R. Weitz, a follower of Warren E. Buffett's investment strategy, spent about $200 million on shares of Wal-Mart Stores Inc. and Tyco International Ltd. in the second quarter as he tried to revive his Weitz Value Fund. The $4 billion fund, one of its category's best performers for much of the 1990s and during the three-year bear market that ended in 2002, is down 7 percent this year. Weitz Value ranks 95th in its class of 96 funds tracked by Bloomberg, beating only the $34.4 million Dreyfus Premier Select Fund.
NEWS
By ANDREW LECKEY | October 2, 2005
I'm considering purchasing shares of Royce Value Fund. What is your opinion? K.T., via the Internet It has a clear strategy that has paid off handsomely for investors since the fund's inception in 2001. This knowledgeable fund specializing in small-cap stocks owns about 60 stock names, unlike some rivals that have 200 or more. By avoiding the smallest micro-cap stocks and sticking with more established names in the $500 million to $5 billion market-cap range, it is less volatile than most of its peers.
NEWS
By Andrew Leckey | March 20, 2005
Supersize me. Individual investors, institutions and pension funds love to own giant stocks that command everyone's attention. Market capitalization is computed by taking the total number of shares and multiplying by the share price. The stocks with the largest capitalization earned their popularity because their companies were quicker, shrewder and more forceful than the competition. Investors in these stocks expect the winning ways to continue, providing a foundation for their portfolios.
NEWS
By MATT LUBANKO | February 6, 2005
About nine years ago, I invested $20,000 in Merrill Lynch Large Cap Value Fund Class B shares (ticker symbol: MBLVX). Not too long ago, I checked out my monthly statement and noticed they switched to Class A shares. They did this without telling me. When I asked why it was done, my broker gave me an unsatisfactory explanation. Why did this happen? - H.N., Chicago You've probably witnessed a conversion: a time-release changeover from Class B shares to Class A shares. There is nothing sinister about this change.
NEWS
By JAY HANCOCK | November 21, 2004
THERE IS money to be made if Omnicare Inc. succeeds in its drawn-out takeover raid of Baltimore's NeighborCare Inc. NeighborCare stock closed Friday at $28.05. Omnicare is offering $30. That's a potential 7 percent return, putting the deal near the top of Bloomberg's list of theoretical "arbitrage" profits from pending mergers. Or more than 7 percent if Omnicare sweetens the package. But will the deal ever get done? "That's a good question, isn't it?" says Frank G. Morgan, who follows the stock of both companies for Jefferies & Co. He doesn't know the answer.
NEWS
By CHARLES JAFFE | October 24, 2004
WHENEVER A mutual fund company makes an announcement designed to build the public's excitement and interest, investors should start looking for the answer to one simple question: "What's the big deal?" Generally, there is barely a small deal. As long-term investment vehicles, funds don't generate much must-know-it-today news, which is why shareholders need to be able to discern the difference between real news and lame self-promotion. To see the latter, look no further than a news release issued recently by the Preferred International Value Fund.